What is the treatment for postoperative ileus after a cesarean section (C-section)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for postoperative ileus after a cesarean section should prioritize a multifaceted approach to minimize its occurrence and impact, as recommended by the most recent guidelines from 2023 1. This approach includes:

  • Minimally invasive surgery, when possible
  • Optimized fluid management to avoid overload
  • Opioid-sparing analgesia to reduce the risk of opioid-induced bowel dysfunction
  • Early mobilization to stimulate bowel function
  • Early postoperative food intake to maintain intestinal function
  • Laxative administration, as needed
  • Omission or early removal of nasogastric tubes to reduce the risk of gastric stasis and aspiration

Key interventions to consider:

  • Chewing gum for 30-60 minutes, three times daily, to stimulate the cephalic-vagal reflex and promote gastrointestinal motility, as supported by studies such as 1
  • Alvimopan, a peripherally acting mu-opioid receptor antagonist, to counteract opioid-induced bowel dysfunction, as discussed in 1 and 1
  • Prokinetic agents like metoclopramide or erythromycin, which stimulate gastrointestinal motility, although their effectiveness may vary as seen in 1
  • Non-opioid alternatives for pain control, such as NSAIDs and acetaminophen, to minimize opioid use

It's essential to tailor the treatment approach to the individual patient's needs and to monitor for signs of complications, such as intra-abdominal infection or mechanical obstruction, if the ileus persists beyond 5-7 days. The most recent and highest quality studies, such as those from 2023 1, should guide clinical decision-making to optimize outcomes in terms of morbidity, mortality, and quality of life.

From the FDA Drug Label

Postoperative ileus is the impairment of gastrointestinal motility after intra-abdominal surgery or other, non-abdominal surgeries. Following oral administration, alvimopan antagonizes the peripheral effects of opioids on gastrointestinal motility and secretion by competitively binding to gastrointestinal tract µ-opioid receptors.

The treatment for postoperative ileus after a cesarean section (C-section) is alvimopan (PO), which antagonizes the peripheral effects of opioids on gastrointestinal motility and secretion by competitively binding to gastrointestinal tract µ-opioid receptors 2.

  • Key points:
    • Alvimopan is a selective antagonist of the cloned human µ-opioid receptor.
    • It achieves selective gastrointestinal opioid antagonism without reversing the central analgesic effects of µ-opioid agonists.
    • The recommended dosage is 12 mg administered twice daily. Note: The FDA label does provide information on the treatment of postoperative ileus, and alvimopan is indicated for this use 2, 2.

From the Research

Treatment for Postoperative Ileus after C-Section

The treatment for postoperative ileus after a cesarean section (C-section) involves a combination of approaches to manage the condition and accelerate gastrointestinal recovery. Some of the key treatment options include:

  • Limiting the use of narcotics and substituting alternative medications such as nonsteroidals 3
  • Placing a thoracic epidural with local anesthetic when possible 3
  • Selective use of nasogastric decompression and correction of electrolyte imbalances 3
  • Stimulation of ambulation and stopping opioids 4
  • Total parenteral nutrition from the 7th day without sufficient oral intake 4

Medications for Postoperative Ileus

Alvimopan, a peripherally acting mu opioid receptor antagonist, has been shown to accelerate gastrointestinal recovery and time to hospital discharge order written compared to placebo in patients undergoing major abdominal surgery, including C-section 5, 6. The medication can be administered orally 2 hours before surgery and twice daily thereafter until discharge or for up to seven days 5.

Prevention of Postoperative Ileus

Preventive measures can help decrease the risk of postoperative ileus, including:

  • Narcotic sparing analgesia 4
  • Fluid optimization 4
  • Stimulation of ambulation 4

Note: While these studies provide evidence for the treatment and prevention of postoperative ileus, they may not be directly specific to C-sections. However, the principles of managing postoperative ileus can be applied to various types of surgery, including C-sections.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.